Table 4. Surgical and pathologic results (intention-to-treat population; n=43).
|
FLO (n=22) |
FLOT (n=21) |
Total (n=43) |
||||
|---|---|---|---|---|---|---|
| Parameter | No. | % | No. | % | No | % |
| Time from random assignment to surgery, days, median; IQR |
73
68–78 |
87 79–90 | 78 70–86 | |||
|
Type of surgery | ||||||
| No Surgery |
5 |
22.7 |
6 |
28.6 |
11 |
25.6 |
|
Transhiatal extended | ||||||
| Gastrectomy |
5 |
22.7 |
5 |
23.8 |
10 |
23.3 |
| Esophagogastrectomy |
3 |
13.6 |
6 |
28.6 |
9 |
20.9 |
| Total/subtotal Gastrectomy |
9 |
40.9 |
4 |
19.4 |
13 |
30.2 |
|
Extend of resection | ||||||
| No Resection |
5 |
22.7 |
6 |
28.6 |
11 |
25.6 |
| R0 |
15 |
68.2 |
14 |
66.6 |
29 |
67.4 |
| R1/2 |
2 |
9.1 |
1 |
4.8 |
3 |
7.0 |
|
Tumour stage | ||||||
| ypT0 |
0 |
|
2 |
9.5 |
2 |
4.7 |
| ypT1/2 |
15 |
68.2 |
10 |
47.6 |
25 |
58.1 |
| ypT3/4 |
1 |
4.5 |
1 |
4.8 |
2 |
4.7 |
| Not evaluable |
1 |
4.5 |
2 |
9.5 |
3 |
7.40 |
|
Nodal status | ||||||
| ypN0 |
7 |
31.8 |
6 |
28.6 |
13 |
30.2 |
| ypN+ |
9 |
40.9 |
8 |
38.1 |
17 |
39.5 |
| Not evaluable |
1 |
4.5 |
1 |
4.8 |
2 |
4.7 |
|
Metastatic status | ||||||
| M0 |
16 |
72.7 |
15 |
71.4 |
31 |
72.1 |
| M1 |
1 |
4.5 |
0 |
|
1 |
2.3 |
|
Median no. of nodes removed | ||||||
| Median IQR (1st quartile–3rd quartile) | 22.5 20–26 | 20 (18.5–21.5) | 21 18.5–24 | |||
Abbrevations: FLO=oxaliplatin, fluorouracil; FLOT=fluorouracil, oxaliplatin, docetaxel; IQR=interquartile range.